Skip to main content
Erschienen in:

05.10.2017 | Original Communication

Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy

verfasst von: Haruki Koike, Tomohiko Nakamura, Atsushi Hashizume, Ryoji Nishi, Shohei Ikeda, Yuichi Kawagashira, Masahiro Iijima, Masahisa Katsuno, Gen Sobue

Erschienen in: Journal of Neurology | Ausgabe 11/2017

Einloggen, um Zugang zu erhalten

Abstract

The objective of this study was to systematically investigate cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy (FAP ATTR Val30Met) patients from non-endemic areas. The coefficient of variation of R–R intervals (CVR-R), responses to the Valsalva manoeuvre, head-up tilt test with impedance cardiography, noradrenaline infusion test, and (123)I-metaiodobenzylguanidine (MIBG) myocardial scintigraphy were assessed in eight patients. Although only four patients manifested orthostatic hypotension during the head-up tilt test, CVR-R, responses to the Valsalva manoeuvre, and myocardial MIBG uptake indicated a higher prevalence of cardiac sympathetic and parasympathetic dysfunction. Total peripheral resistance at 60° tilt did not increase from baseline values in five of six examined patients. An infusion of low-dose noradrenaline induced an increase in systolic blood pressure in all patients. The extent of the change in systolic blood pressure negatively correlated to that in total peripheral resistance (p < 0.05). Patients with poor vasoconstrictor responses to orthostatic stress tended to exhibit severe reduction of unmyelinated fibres in sural nerve biopsy specimens. In conclusion, both cardiac and peripheral vasomotor autonomic dysfunctions were prevalent in late-onset FAP ATTR Val30Met patients from non-endemic areas, even in those without orthostatic intolerance. However, vasoconstriction by alpha-adrenoceptor agonists was preserved even after denervation, carrying important implications for the management of orthostatic hypotension in FAP.
Literatur
1.
Zurück zum Zitat Ikeda SI, Makishita H, Oguchi K, Yanagisawa N, Nagata T (1982) Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology 32:1364–1368CrossRefPubMed Ikeda SI, Makishita H, Oguchi K, Yanagisawa N, Nagata T (1982) Gastrointestinal amyloid deposition in familial amyloid polyneuropathy. Neurology 32:1364–1368CrossRefPubMed
2.
Zurück zum Zitat Ando Y, Nakamura M, Araki S (2005) Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62:1057–1062CrossRefPubMed Ando Y, Nakamura M, Araki S (2005) Transthyretin-related familial amyloidotic polyneuropathy. Arch Neurol 62:1057–1062CrossRefPubMed
3.
Zurück zum Zitat Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411–423CrossRefPubMed Benson MD, Kincaid JC (2007) The molecular biology and clinical features of amyloid neuropathy. Muscle Nerve 36:411–423CrossRefPubMed
4.
Zurück zum Zitat Planté-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10:1086–1097CrossRefPubMed Planté-Bordeneuve V, Said G (2011) Familial amyloid polyneuropathy. Lancet Neurol 10:1086–1097CrossRefPubMed
5.
Zurück zum Zitat Sekijima Y (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 86:1036–1043CrossRefPubMed Sekijima Y (2015) Transthyretin (ATTR) amyloidosis: clinical spectrum, molecular pathogenesis and disease-modifying treatments. J Neurol Neurosurg Psychiatry 86:1036–1043CrossRefPubMed
6.
Zurück zum Zitat Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G, Study Group for Hereditary Neuropathy in Japan (2002) Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol 59:1771–1776CrossRefPubMed Koike H, Misu K, Ikeda S, Ando Y, Nakazato M, Ando E, Yamamoto M, Hattori N, Sobue G, Study Group for Hereditary Neuropathy in Japan (2002) Type I (transthyretin Met30) familial amyloid polyneuropathy in Japan: early- vs late-onset form. Arch Neurol 59:1771–1776CrossRefPubMed
7.
Zurück zum Zitat Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G (2011) Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18:53–62CrossRefPubMed Koike H, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Tanaka F, Sobue G (2011) Diagnosis of sporadic transthyretin Val30Met familial amyloid polyneuropathy: a practical analysis. Amyloid 18:53–62CrossRefPubMed
8.
Zurück zum Zitat Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, Slama MS, Hazenberg BP, Coelho T, European Network for TTR-FAP (ATTReuNET) (2016) First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol 29(Suppl 1):S14–S26CrossRefPubMedPubMedCentral Adams D, Suhr OB, Hund E, Obici L, Tournev I, Campistol JM, Slama MS, Hazenberg BP, Coelho T, European Network for TTR-FAP (ATTReuNET) (2016) First European consensus for diagnosis, management, and treatment of transthyretin familial amyloid polyneuropathy. Curr Opin Neurol 29(Suppl 1):S14–S26CrossRefPubMedPubMedCentral
9.
Zurück zum Zitat Chao CC, Huang CM, Chiang HH, Luo KR, Kan HW, Yang NC, Chiang H, Lin WM, Lai SM, Lee MJ, Shun CT, Hsieh ST (2015) Sudomotor innervation in transthyretin amyloid neuropathy: pathology and functional correlates. Ann Neurol 78:272–283CrossRefPubMedPubMedCentral Chao CC, Huang CM, Chiang HH, Luo KR, Kan HW, Yang NC, Chiang H, Lin WM, Lai SM, Lee MJ, Shun CT, Hsieh ST (2015) Sudomotor innervation in transthyretin amyloid neuropathy: pathology and functional correlates. Ann Neurol 78:272–283CrossRefPubMedPubMedCentral
10.
Zurück zum Zitat Castro J, Miranda B, Castro I, de Carvalho M, Conceição I (2016) The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy. Clin Neurophysiol 127:2222–2227CrossRefPubMed Castro J, Miranda B, Castro I, de Carvalho M, Conceição I (2016) The diagnostic accuracy of Sudoscan in transthyretin familial amyloid polyneuropathy. Clin Neurophysiol 127:2222–2227CrossRefPubMed
11.
Zurück zum Zitat Rousseau A, Cauquil C, Dupas B, Labbé A, Baudouin C, Barreau E, Théaudin M, Lacroix C, Guiochon-Mantel A, Benmalek A, Labetoulle M, Adams D (2016) Potential role of in vivo confocal microscopy for imaging corneal nerves in transthyretin familial amyloid polyneuropathy. JAMA Ophthalmol 134:983–989CrossRefPubMed Rousseau A, Cauquil C, Dupas B, Labbé A, Baudouin C, Barreau E, Théaudin M, Lacroix C, Guiochon-Mantel A, Benmalek A, Labetoulle M, Adams D (2016) Potential role of in vivo confocal microscopy for imaging corneal nerves in transthyretin familial amyloid polyneuropathy. JAMA Ophthalmol 134:983–989CrossRefPubMed
12.
Zurück zum Zitat Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Fujitake J, Kawanami T, Kato T, Yamamoto M, Sobue G (2012) Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83:152–158CrossRefPubMed Koike H, Tanaka F, Hashimoto R, Tomita M, Kawagashira Y, Iijima M, Fujitake J, Kawanami T, Kato T, Yamamoto M, Sobue G (2012) Natural history of transthyretin Val30Met familial amyloid polyneuropathy: analysis of late-onset cases from non-endemic areas. J Neurol Neurosurg Psychiatry 83:152–158CrossRefPubMed
13.
Zurück zum Zitat Niklasson U, Olofsson BO, Bjerle P (1989) Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand 79:182–187CrossRefPubMed Niklasson U, Olofsson BO, Bjerle P (1989) Autonomic neuropathy in familial amyloidotic polyneuropathy. A clinical study based on heart rate variability. Acta Neurol Scand 79:182–187CrossRefPubMed
14.
Zurück zum Zitat Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, Dollé F, Mzabi H, Samuel D, Adams D, Syrota A, Merlet P (2001) Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 104:2911–2916CrossRefPubMed Delahaye N, Le Guludec D, Dinanian S, Delforge J, Slama MS, Sarda L, Dollé F, Mzabi H, Samuel D, Adams D, Syrota A, Merlet P (2001) Myocardial muscarinic receptor upregulation and normal response to isoproterenol in denervated hearts by familial amyloid polyneuropathy. Circulation 104:2911–2916CrossRefPubMed
15.
Zurück zum Zitat Ando Y, Obayashi K, Tanaka Y, Tsuji T, Uchino M, Takahashi M, Ando M (1994) Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction. Lancet 343:984–985CrossRefPubMed Ando Y, Obayashi K, Tanaka Y, Tsuji T, Uchino M, Takahashi M, Ando M (1994) Radiolabelled meta-iodobenzylguanidine in assessment of autonomic dysfunction. Lancet 343:984–985CrossRefPubMed
16.
Zurück zum Zitat Obayashi K, Ando Y, Nakamura M, Yamashita T, Ueda M, Haraoka K, Terazaki H, Uchino M (2004) Near-infrared spectrophotoscopy of finger venules in assessment of autonomic dysfunction. Neurology 63:164–166CrossRefPubMed Obayashi K, Ando Y, Nakamura M, Yamashita T, Ueda M, Haraoka K, Terazaki H, Uchino M (2004) Near-infrared spectrophotoscopy of finger venules in assessment of autonomic dysfunction. Neurology 63:164–166CrossRefPubMed
17.
Zurück zum Zitat Obayashi K, Ando Y, Nakamura M, Terazaki H, Yamashita T, Tashima K, Suga M, Uchino M, Ando M (2000) Endothelium-dependent vasodilatation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 23:1084–1088CrossRefPubMed Obayashi K, Ando Y, Nakamura M, Terazaki H, Yamashita T, Tashima K, Suga M, Uchino M, Ando M (2000) Endothelium-dependent vasodilatation in patients with familial amyloidotic polyneuropathy. Muscle Nerve 23:1084–1088CrossRefPubMed
18.
Zurück zum Zitat Hörnsten R, Suhr OB, Jensen SM, Wiklund U (2008) Outcome of heart rate variability and ventricular late potentials after liver transplantation for familial amyloidotic polyneuropathy. Amyloid 15:187–195CrossRefPubMed Hörnsten R, Suhr OB, Jensen SM, Wiklund U (2008) Outcome of heart rate variability and ventricular late potentials after liver transplantation for familial amyloidotic polyneuropathy. Amyloid 15:187–195CrossRefPubMed
19.
Zurück zum Zitat Watanabe H, Misu K, Hirayama M, Hattori N, Yoshihara T, Doyu M, Sobue G (2001) Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30). J Neurol 248:627–629CrossRefPubMed Watanabe H, Misu K, Hirayama M, Hattori N, Yoshihara T, Doyu M, Sobue G (2001) Low cardiac 123I-MIBG uptake in late-onset familial amyloid polyneuropathy type I (TTR Met30). J Neurol 248:627–629CrossRefPubMed
20.
Zurück zum Zitat Kim DH, Zeldenrust SR, Low PA, Dyck PJ (2009) Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy. Muscle Nerve 40:363–370CrossRefPubMedPubMedCentral Kim DH, Zeldenrust SR, Low PA, Dyck PJ (2009) Quantitative sensation and autonomic test abnormalities in transthyretin amyloidosis polyneuropathy. Muscle Nerve 40:363–370CrossRefPubMedPubMedCentral
21.
Zurück zum Zitat Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Disord 26:1869–1874CrossRefPubMed Nakamura T, Hirayama M, Hara T, Hama T, Watanabe H, Sobue G (2011) Does cardiovascular autonomic dysfunction contribute to fatigue in Parkinson’s disease? Mov Disord 26:1869–1874CrossRefPubMed
22.
Zurück zum Zitat Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H, Hirayama M, Katsuno M, Sobue G (2016) Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disord 31:1417–1421CrossRefPubMed Nakamura T, Suzuki M, Okada A, Suzuki J, Hasegawa S, Koike H, Hirayama M, Katsuno M, Sobue G (2016) Association of leptin with orthostatic blood pressure changes in Parkinson’s disease. Mov Disord 31:1417–1421CrossRefPubMed
23.
Zurück zum Zitat Suzuki J, Nakamura T, Hirayama M, Mizutani Y, Okada A, Ito M, Watanabe H, Sobue G (2015) Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Parkinsonism Relat Disord 21:917–922CrossRefPubMed Suzuki J, Nakamura T, Hirayama M, Mizutani Y, Okada A, Ito M, Watanabe H, Sobue G (2015) Impaired peripheral vasoconstrictor response to orthostatic stress in patients with multiple system atrophy. Parkinsonism Relat Disord 21:917–922CrossRefPubMed
24.
Zurück zum Zitat Suzuki M, Nakamura T, Hirayama M, Ueda M, Katsuno M, Sobue G (2017) Cardiac parasympathetic dysfunction in the early phase of Parkinson’s disease. J Neurol 264:333–340CrossRefPubMed Suzuki M, Nakamura T, Hirayama M, Ueda M, Katsuno M, Sobue G (2017) Cardiac parasympathetic dysfunction in the early phase of Parkinson’s disease. J Neurol 264:333–340CrossRefPubMed
25.
Zurück zum Zitat Hirata K, Katayama S (1992) The coefficient of variation of R-R intervals. In: Japanese Society of Neurovegetative Research (ed) Autonomic function test, 2nd edn. Bunkodo, Tokyo, pp 48–56 (in Japanese) Hirata K, Katayama S (1992) The coefficient of variation of R-R intervals. In: Japanese Society of Neurovegetative Research (ed) Autonomic function test, 2nd edn. Bunkodo, Tokyo, pp 48–56 (in Japanese)
26.
Zurück zum Zitat Novak P (2011) Quantitative autonomic testing. J Vis Exp 53:e2502 Novak P (2011) Quantitative autonomic testing. J Vis Exp 53:e2502
28.
Zurück zum Zitat Nakamura T, Hirayama M, Hara T, Mizutani Y, Suzuki J, Watanabe H, Sobue G (2014) Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord 20:409–414CrossRefPubMed Nakamura T, Hirayama M, Hara T, Mizutani Y, Suzuki J, Watanabe H, Sobue G (2014) Role of cardiac sympathetic nerves in preventing orthostatic hypotension in Parkinson’s disease. Parkinsonism Relat Disord 20:409–414CrossRefPubMed
29.
Zurück zum Zitat Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, Takahashi A (1999) Clinical and physiological characteristics of autonomic failure with Parkinson’s disease. Clin Auton Res 9:139–144CrossRefPubMed Niimi Y, Ieda T, Hirayama M, Koike Y, Sobue G, Hasegawa Y, Takahashi A (1999) Clinical and physiological characteristics of autonomic failure with Parkinson’s disease. Clin Auton Res 9:139–144CrossRefPubMed
30.
Zurück zum Zitat Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, Koike Y, Sobue G (2003) Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:423–426CrossRefPubMedPubMedCentral Hamada K, Hirayama M, Watanabe H, Kobayashi R, Ito H, Ieda T, Koike Y, Sobue G (2003) Onset age and severity of motor impairment are associated with reduction of myocardial 123I-MIBG uptake in Parkinson’s disease. J Neurol Neurosurg Psychiatry 74:423–426CrossRefPubMedPubMedCentral
31.
Zurück zum Zitat Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25:1183–1189CrossRefPubMed Nakamura T, Hirayama M, Yamashita F, Uchida K, Hama T, Watanabe H, Sobue G (2010) Lowered cardiac sympathetic nerve performance in response to exercise in Parkinson’s disease. Mov Disord 25:1183–1189CrossRefPubMed
32.
Zurück zum Zitat Nakajima K, Nakata T (2015) Cardiac 123I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med 56(Suppl 4):11S–19SCrossRefPubMed Nakajima K, Nakata T (2015) Cardiac 123I-MIBG imaging for clinical decision making: 22-year experience in Japan. J Nucl Med 56(Suppl 4):11S–19SCrossRefPubMed
33.
Zurück zum Zitat Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Sobue G (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63:129–138CrossRefPubMed Koike H, Misu K, Sugiura M, Iijima M, Mori K, Yamamoto M, Hattori N, Mukai E, Ando Y, Ikeda S, Sobue G (2004) Pathology of early- vs late-onset TTR Met30 familial amyloid polyneuropathy. Neurology 63:129–138CrossRefPubMed
34.
Zurück zum Zitat Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G (2016) Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 87:2220–2229CrossRefPubMed Koike H, Ikeda S, Takahashi M, Kawagashira Y, Iijima M, Misumi Y, Ando Y, Ikeda SI, Katsuno M, Sobue G (2016) Schwann cell and endothelial cell damage in transthyretin familial amyloid polyneuropathy. Neurology 87:2220–2229CrossRefPubMed
35.
Zurück zum Zitat van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607CrossRefPubMed van Swieten JC, Koudstaal PJ, Visser MC, Schouten HJ, van Gijn J (1988) Interobserver agreement for the assessment of handicap in stroke patients. Stroke 19:604–607CrossRefPubMed
36.
Zurück zum Zitat Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M, Ando M (1995) Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 345:195–196CrossRefPubMed Ando Y, Tanaka Y, Ando E, Yamashita T, Nishida Y, Tashima K, Suga M, Uchino M, Ando M (1995) Effect of liver transplantation on autonomic dysfunction in familial amyloidotic polyneuropathy type I. Lancet 345:195–196CrossRefPubMed
37.
Zurück zum Zitat Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G (2000) The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123:1495–1504CrossRefPubMed Adams D, Samuel D, Goulon-Goeau C, Nakazato M, Costa PM, Feray C, Planté V, Ducot B, Ichai P, Lacroix C, Metral S, Bismuth H, Said G (2000) The course and prognostic factors of familial amyloid polyneuropathy after liver transplantation. Brain 123:1495–1504CrossRefPubMed
38.
Zurück zum Zitat Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A, Slama MS, Le Guludec D (2006) Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 85:229–238CrossRef Delahaye N, Rouzet F, Sarda L, Tamas C, Dinanian S, Plante-Bordeneuve V, Adams D, Samuel D, Merlet P, Syrota A, Slama MS, Le Guludec D (2006) Impact of liver transplantation on cardiac autonomic denervation in familial amyloid polyneuropathy. Medicine (Baltimore) 85:229–238CrossRef
39.
Zurück zum Zitat Coutinho MC, Cortez-Dias N, Cantinho G, Conceição I, Oliveira A, Bordalo e Sá A, Gonçalves S, Almeida AG, de Carvalho M, Diogo AN (2013) Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging 6:627–636CrossRefPubMed Coutinho MC, Cortez-Dias N, Cantinho G, Conceição I, Oliveira A, Bordalo e Sá A, Gonçalves S, Almeida AG, de Carvalho M, Diogo AN (2013) Reduced myocardial 123-iodine metaiodobenzylguanidine uptake: a prognostic marker in familial amyloid polyneuropathy. Circ Cardiovasc Imaging 6:627–636CrossRefPubMed
40.
Zurück zum Zitat Low PA (2015) Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care 21(13 Suppl):s248–s257PubMed Low PA (2015) Neurogenic orthostatic hypotension: pathophysiology and diagnosis. Am J Manag Care 21(13 Suppl):s248–s257PubMed
41.
Zurück zum Zitat Figueroa JJ, Dyck PJ, Laughlin RS, Mercado JA, Massie R, Sandroni P, Dyck PJ, Low PA (2012) Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 78:702–708CrossRefPubMedPubMedCentral Figueroa JJ, Dyck PJ, Laughlin RS, Mercado JA, Massie R, Sandroni P, Dyck PJ, Low PA (2012) Autonomic dysfunction in chronic inflammatory demyelinating polyradiculoneuropathy. Neurology 78:702–708CrossRefPubMedPubMedCentral
Metadaten
Titel
Cardiac and peripheral vasomotor autonomic functions in late-onset transthyretin Val30Met familial amyloid polyneuropathy
verfasst von
Haruki Koike
Tomohiko Nakamura
Atsushi Hashizume
Ryoji Nishi
Shohei Ikeda
Yuichi Kawagashira
Masahiro Iijima
Masahisa Katsuno
Gen Sobue
Publikationsdatum
05.10.2017
Verlag
Springer Berlin Heidelberg
Erschienen in
Journal of Neurology / Ausgabe 11/2017
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI
https://doi.org/10.1007/s00415-017-8629-2

Kompaktes Leitlinien-Wissen Neurologie (Link öffnet in neuem Fenster)

Mit medbee Pocketcards schnell und sicher entscheiden.
Leitlinien-Wissen kostenlos und immer griffbereit auf ihrem Desktop, Handy oder Tablet.

Neu im Fachgebiet Neurologie

Neuartige Antikörpertherapie bremst MS über zwei Jahre hinweg

Eine Therapie mit dem C40-Ligand-Blocker Frexalimab kann MS-Schübe und neue MRT-Läsionen über zwei Jahre hinweg verhindern. Dafür spricht die Auswertung einer offen fortgeführten Phase-2-Studie.

Positive Phase IIb-Studie zu mRNA-gestützter CAR-T bei Myasthenia gravis

Eine auf das B-Zell-Reifungsantigen gerichtete mRNA-basierte CAR-T-Zell-Therapie wurde jetzt in einer ersten Phase IIb-Studie zur Behandlung der generalisierten Myasthenia gravis mit Placebo verglichen.

Therapiestopp bei älteren MS-Kranken kann sich lohnen

Eine Analyse aus Kanada bestätigt: Setzen ältere MS-Kranke die Behandlung mit Basistherapeutika ab, müssen sie kaum mit neuen Schüben und MRT-Auffälligkeiten rechnen.

Schadet Schichtarbeit dem Gehirn?

Eine große Registerstudie bestätigt, dass Schichtarbeit mit einem erhöhten Risiko für psychische und neurologische Erkrankungen einhergeht, sowie mit einer Volumenabnahme in Gehirnarealen, die für Depression, Angst und kognitive Funktionen relevant sind.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.